The WGNV is an informal network of stakeholders engaged in all aspects of TB vaccine R&D - including TB vaccine advocacy - and from all constituencies, including researchers, academicians, product developers, clinicians, advocates, funders, policymakers, and affected communities. The WGNV helps to facilitate the development of new, more effective TB vaccines by promoting consensus, scientific exchange, and advocacy in support of TB vaccine R&D.

How to Get Involved

Join the WGNV

Members will be kept informed of new developments in TB vaccine R&D and opportunities to engage in efforts to advance TB vaccine R&D, including current TB vaccine advocacy activities.

Get involved with the TB Vaccine Advocacy Roadmap (TB Vax ARM)

The TB Vax ARM represents a global coalition of TB stakeholders, including TB survivors, civil society organizations, and non-profits, invested in TB vaccine advocacy and research, and seeks to provide coordinated advocacy efforts that are complementary to ongoing TB vaccine R&D and policy efforts. The TB Vax ARM holds monthly advocacy meetings with partners from across the world. WGNV coordinates with the TB Vax ARM on global advocacy activities.

Check out our resources

Learn more about TB vaccine R&D, the state of the field, and discover key resources in the Advocacy & Community section of our resource page, including key content, such as:

Check out our digital advocacy resources

Discover digital advocacy resources that you can use in your own online advocacy, including:

TB Vaccine Advocacy Fellowship 2023

The TB Vax ARM and the WGNV, in collaboration with IAVI, hosted seven participants in the TB vaccine advocacy fellowship in February and March 2023. The fellows, representing affected community members, advocates, and early career researchers from five different countries, came together for an online skill-sharing and co-creation program. The fellowship featured a lineup of workshops led by advocacy experts from around the world to help the fellows hone their skills to develop and contribute to future advocacy campaigns.

TB Vax ARM Quotes_Feb 22 Action (1)

Together, the fellows developed an open letter campaign demanding that world leaders make ending TB possible and help create a healthier, more equitable, and TB free world! Signed by over 1,180 individuals and organizations from over 90 countries, the letter will play an important part in amplifying the voices of the global TB community in demanding new TB vaccines at the United Nations High-Level Meeting on TB in September.

Are you involved in or planning an advocacy initiative to support TB vaccine R&D? Contact us!

Previous Advocacy Activities

Open Letter campaigns

Since the TB Vax ARM was convened in May 2021, the coalition has launched two open letter campaigns, calling world leaders to fulfil fundings commitments to make new TB vaccines a reality. The first addressed the G20 ministers of health and finance in October 2021 (also featured in an article in the Guardian Global Development) with the second targeting EU leadership in February 2022. Both campaigns have received support from the global TB community, including TB survivors from all G20 states and over 90 organizations, and have reached over 1 million screens on social media.


Social Media Advocacy Fellowship 2022

At the beginning of February 2022, IAVI launched a social media fellowship as part of the TB Vax ARM efforts. Cheleka Mpande, Gloriah Moses, and Krystyna Rivera, three TB vaccine R&D advocates representing TB affected communities and early career researchers, came together for an intensive two-week social media skill building and campaign development program.


The fellows developed and ran a social media-based TB vaccine R&D advocacy campaign in the lead up to the 6th Global Forum on TB Vaccines, where they called upon members of the global TB community to #Unite4TBVax by sharing how they are helping to make new TB vaccines a reality on the campaign Kudoboard. You can share what your role on the #Unite4TBVax message board

Join the WGNV or subscribe to the WGNV email list to learn more about upcoming advocacy initiatives and opportunities.